AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 152 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $197,000 | -53.4% | 13,041 | -76.9% | 0.00% | – |
| Q2 2022 | $423,000 | -3.0% | 56,463 | -9.0% | 0.00% | – |
| Q4 2021 | $436,000 | +54.6% | 62,058 | +150.7% | 0.00% | – |
| Q3 2021 | $282,000 | +13.3% | 24,754 | +78.2% | 0.00% | – |
| Q1 2021 | $249,000 | -64.7% | 13,893 | -73.4% | 0.00% | – |
| Q4 2020 | $706,000 | +380.3% | 52,255 | +318.0% | 0.00% | – |
| Q3 2020 | $147,000 | -65.8% | 12,500 | -57.1% | 0.00% | – |
| Q2 2020 | $430,000 | -77.7% | 29,115 | -63.5% | 0.00% | -100.0% |
| Q4 2019 | $1,929,000 | +105.2% | 79,796 | +63.2% | 0.00% | +50.0% |
| Q3 2019 | $940,000 | +244.3% | 48,900 | +1003.1% | 0.00% | +100.0% |
| Q3 2018 | $273,000 | -84.9% | 4,433 | -83.4% | 0.00% | -75.0% |
| Q2 2018 | $1,804,000 | -2.2% | 26,700 | -13.5% | 0.00% | -33.3% |
| Q4 2017 | $1,844,000 | +59.1% | 30,866 | +29.5% | 0.01% | +50.0% |
| Q3 2017 | $1,159,000 | +172.1% | 23,829 | +194.2% | 0.00% | +300.0% |
| Q2 2017 | $426,000 | +73.9% | 8,100 | +50.0% | 0.00% | 0.0% |
| Q1 2017 | $245,000 | -95.4% | 5,400 | -96.2% | 0.00% | -96.2% |
| Q3 2016 | $5,382,000 | +939.0% | 142,618 | +570.0% | 0.03% | +766.7% |
| Q4 2015 | $518,000 | +18.8% | 21,286 | -13.5% | 0.00% | +50.0% |
| Q3 2015 | $436,000 | +19.8% | 24,602 | +112.0% | 0.00% | -33.3% |
| Q1 2015 | $364,000 | +57.6% | 11,606 | +24.3% | 0.00% | 0.0% |
| Q2 2014 | $231,000 | – | 9,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |